14JUN

Lords question UKRI chief on funding

2 min read

16:35UTC

The House of Lords Science and Technology Committee took oral evidence from UKRI chief executive Sir Ian Chapman on Tuesday 14 July, nine days after the agency confirmed a 58% cut to its national laboratories.

← Back to London startup raises Britain's own AI model Jump to analysis ↓

TechnologyDeveloping

Key takeaway

Peers questioned UKRI's funding approach nine days after it confirmed the laboratory cuts.

The House of Lords Science and Technology Committee took oral evidence from Sir Ian Chapman, chief executive of UK Research and Innovation (UKRI), on Tuesday 14 July, on the agency's approach to funding, with a new strategy expected shortly ¹. UKRI distributes public research money through nine councils and is the single largest funder of British Science. We have the committee's listing for the session, not the transcript, and we are not reporting answers we have not read.

UKRI confirmed a 58% cut to Science and Technology Facilities Council (STFC) national-laboratory funding on 9 July, along with the mothballing of the Clara electron-beam facility . Removing more than half a laboratory network's budget does not slow its instruments down; it switches them off, and a mothballed accelerator is not a paused one. Restarting requires the beamline staff who by then have taken jobs at Grenoble or Hamburg, and specialist instrument engineers do not queue in the departure lounge waiting for a spending review to reverse itself.

That is the machinery a founder should watch, even one whose company has nothing to do with particle physics. National facilities are where deep-tech startups run characterisation they cannot afford in-house, and this topic has spent the month covering companies buying exactly that access from private partners instead.

Deep Analysis

In plain English

UKRI, UK Research and Innovation, is the public body that distributes government research funding through nine councils and is Britain's single largest funder of science. The House of Lords Science and Technology Committee is a group of peers who scrutinise government science policy; it is a separate body from the House of Commons committee with a similar name, and the two should not be confused. On 14 July, the Lords committee took oral evidence from UKRI's chief executive, Sir Ian Chapman, about the agency's approach to funding, with a new strategy expected soon. We have confirmation the session happened and its subject, from the committee's own published listing, but not a transcript or recording of what was actually said, so this briefing reports that the hearing took place without reporting any answers given inside it.

Deep Analysis

Root Causes

A parliamentary committee normally schedules oral evidence once a funding decision becomes contentious enough to warrant direct questioning of the agency responsible. UKRI's 58% STFC cut and the Clara mothballing, confirmed just five days before this session, is the specific decision that made a hearing on UKRI's funding approach timely rather than routine.

What could happen next?

Meaning
Formal parliamentary scrutiny of UKRI's funding approach began within days of the STFC cuts becoming public, rather than being deferred to the next strategy publication.

Source Landscape

This story draws on neutral-leaning sources

Primary parallel: UKRI confirmed a 58% cut to Science and Technology Facilities Council national-laboratory funding and the mothballing of the Clara facility on 9 July, five days before this hearing. The Lords session on UKRI's funding approach follows directly from that decision, the backdrop scrutiny of this kind normally responds to.

Counter-parallel: The British Business Bank's own accountability runs through published data, its Small Business Equity Tracker on 2 July set out figures anyone can check. This committee session runs the opposite way: we have only the listing confirming it took place, not a transcript of what was actually said, so the two forms of scrutiny this topic tracks are not equally verifiable.

Sources:UK Parliament

Mentions:UKRI →Clara →British Business Bank →Science and Technology Facilities Council →House of Lords Science and Technology Committee →Sir Ian Chapman →

First Reported In

Update #12 · CuspAI pools 45 partners' labs and compute

UK Parliament· 22 Jul 2026

Read original →

Causes and effects

Caused by

UKRI confirms 58% cut to STFC labs

UKRI's confirmed STFC cuts nine days earlier framed the funding-approach questions the Committee put to Chapman.

Occurred 9 Jul 2026

Read story →

This Event

Lords question UKRI chief on funding

A new UKRI strategy is expected shortly, and the Lords session is the first formal scrutiny of the funding approach that produced the laboratory cuts.

Different Perspectives

Fubon Financial

Fubon Financial joined Humanoid's Series A on 21 July as a minority financial investor alongside Schaeffler and Bosch, who also hold the customer and manufacturer roles. A pure-play investor from Taipei is pricing a London robot maker on terms two German industrial groups effectively set.

NATO Innovation Fund

The Fund joined Greenjets' £30m Series A on 21 July alongside NSSIF, betting on ducted electric propulsion's civil market to fund a technology with an obvious defence application. It is backing a company that took twenty-one years to reach this stage, on the expectation that certification-cycle timelines reward patient capital over a quick return.

Prime Movers Lab

Prime Movers Lab led Humanoid's Series A on 21 July as the round's only pure financial investor, sharing the cap table with two co-investors who are also the anchor customer and the factory. That leaves the fund's usual arm's-length pricing role diluted by partners with a direct commercial stake in the valuation holding up.

Bosch and Schaeffler

Schaeffler signed what Humanoid calls the industry's largest publicly announced commercial agreement, while Bosch took equity and became contract manufacturer, filling capacity a shrinking combustion supply chain freed. Neither company has disclosed a unit count or an invoice, so their public commitment stops well short of Forbes' 100,000-unit projection.

UK founders raising seed through Series A

A London robotics founder raised $152m this week against a signed industrial customer and a reserved factory, while a Cornwall founder more typically draws a £25,000 loan from a regional fund manager. Both call it British venture funding, but one route runs through Bosch's production line and the other through diligence built for businesses too small for any VC's attention.

EQT

EQT was reported on 3 July to be in advanced talks for a further CuspAI stake on behalf of the EU's Scaleup Europe Fund, but does not appear on the round CuspAI closed. Whether Europe's own sovereign vehicle secured a position, was outbid, or withdrew is unresolved.